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A B S T R A C T
Human neutrophil elastase (HNE) is a serine protease, produced by polymorphonuclear neutrophils (PMNs),
whose uncontrolled production has been associated with various inﬂammatory disease states as well as tumour
proliferation and metastasis. Here we report the development and characterisation of an electrochemical pep-
tide-based biosensor, which enables the detection of clinically relevant levels of HNE. The sensing platform was
characterised in terms of its analytical performance, enzymatic cleavage kinetics and cross-reactivity and applied
to the quantitative detection of protease activity from PMNs from human blood.
1. Introduction
Human neutrophil elastase (HNE), a serine protease secreted by
polymorphonuclear neutrophils (PMNs), plays an important role in
many physiological and pathological processes (Korkmaz et al., 2008).
The proteolytic activity of this enzyme contributes to the body's defence
against infectious agents by promoting the destruction of pathogenic
bacteria (Meyer-Hoﬀert and Wiedow, 2011; Nathan, 2006). High levels
of unregulated HNE have also been associated with the inﬂammatory
state found in a wide range of acute and chronic diseases
(Kolaczkowska and Kubes, 2013; Pham, 2006) with excess HNE causing
extracellular matrix degradation, cellular receptor cleavage and healthy
tissue disruption (Abe et al., 2009; Chua and Laurent, 2006; Shapiro,
2002). Furthermore, recent studies have suggested a direct role for HNE
in promoting tumour proliferation and metastasis (Galdiero et al., 2013;
Sato et al., 2006). HNE is therefore a potential diagnostic marker for a
number of disease states and detecting it with high sensitivity is clini-
cally important (Henriksen and Sallenave, 2008; Ho et al., 2014;
Korkmaz et al., 2010). Common methods to monitor HNE levels rely on
immunoassays (de la Rebière de Pouyade et al., 2010; Dunn et al.,
1985) and aptamer or peptide-based sensors typically labelled with
ﬂuorescent reporters (Avlonitis et al., 2013; Bai et al., 2017; Ferreira
et al., 2017; He et al., 2010). In this context, it is interesting to note that
electrochemical peptide-based biosensors have proven to be valuable
tools for the detection of protease activity (Anne et al., 2012; Liu et al.,
2006; Shin et al., 2013; Swisher et al., 2015, 2014, 2013) – as well as a
wider range of applications (Huang et al., 2016; Li et al., 2015, 2014;
Puiu et al., 2014). Recently, our research group reported an electro-
chemical peptide-based biosensor which used self-assembled mono-
layers (SAMs) on gold electrodes for the detection of the model protease
trypsin (González-Fernández et al., 2016). This constituted a short
peptide sequence, which acts as substrate for the target enzyme, me-
thylene blue as redox reporter and a polyethylene glycol (PEG) spacer
that was shown to be important in tuning both the anti-fouling prop-
erties and the probe's ﬂexibility (González-Fernández et al., 2018).
Upon enzymatic cleavage, a redox-labelled probe fragment is released,
leading to a measurable decrease in the electrochemical signal. This
system provided a sensitive platform with a clinically relevant limit of
detection (LOD) of 250 pM. Building on this approach, here we target
the translation of this model system to the detection of HNE in biolo-
gical (human blood) samples through the development of a novel me-
thylene blue-tagged peptide-based biosensor with an HNE-speciﬁc
cleavage sequence employing ternary SAMs on a gold surface. This is
the ﬁrst reported example of HNE detection based on a reagent-free
labelled electrochemical strategy.
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2. Materials and methods
2.1. Instrumentation
Electrochemical measurements were performed using a conven-
tional three-electrode electrochemical cell driven by a computer-con-
trolled AutoLab PGstat-30 potentiostat running the GPES 4.9 software
(EcoChemie, The Netherlands). A platinum wire and a 2mm diameter
polycrystalline gold electrode (IJ Cambria, UK) were used as auxiliary
and working electrodes, respectively. All the potentials were referenced
to a Ag│AgCl│KCl (3M) reference electrode (Bioanalytical Systems,
Inc., USA). MALDI TOF MS were run on a Bruker Ultraﬂextreme MALDI
TOF/TOF with a matrix solution of sinapic acid (10mg/mL) in H2O/
CH3CN/TFA (50/50/0.1).
2.2. Reagents
Human neutrophil elastase, HNE (MW 29.5 kDa) was obtained from
Athens Research and Technology Inc. (USA). Cathepsin G, bovine serum
albumin (BSA), casein, 6-mercaptohexanol (MCH), 2,2′-(ethylenedioxy)
diethanethiol (PDT), HEPES buﬀer, sodium chloride, sodium acetate
were all obtained from Sigma. All reagents were of analytical grade and
solutions were prepared using protease-free deionised water. HNE was
reconstituted in 50mM acetate, pH 5.5, with 150mM NaCl and stored
at −80 °C until use.
2.3. Experimental methods
2.3.1. Synthesis
The detailed synthetic experimental procedures are described in
Appendix A: Supplementary Data.
2.3.2. Electrode cleaning and pre-treatment
After immersing in the minimum volume of piranha solution (3:1-
H2SO4 (95%): H2O2 (33%)) (CAUTION piranha solution is strongly
oxidising and must be handled with care!) for 10min in order to
eliminate any organic matter from the gold surface, the working elec-
trode was successively polished on a polishing cloth using alumina
slurries of 1, 0.3 and 0.05 µm particle size (Buehler, Germany).
Afterwards, this electrode was further cleaned by immersion in H2SO4
(95%) and then HNO3 (65%) at room temperature for 10min. Finally,
the working electrode was subjected to cyclic voltammetry, carrying
out potential cycles between 0 and +1.6 V in 0.1M H2SO4 at a scan
rate of 100mV s−1 until the characteristic voltammogram of clean
polycrystalline gold was obtained.
2.3.3. Sensing phase preparation protocol
The sensing phase was formed as a mixed SAM on the gold electrode
surface by immersing the freshly cleaned and pre-treated gold working
electrode overnight at 4 °C in a 40 µM ethanolic solution of the appro-
priate redox-labelled peptide (substrate, composed of L-amino acids; or
control, with all amino acids replaced with their respective D-amino
acid analogues) and freshly prepared PDT (600 µM). After washing with
ethanol, the resulting SAM-modiﬁed electrode was immersed in 1mM
MCH in ethanol for 1 h at room temperature. Finally, two washing steps
were carried out, ﬁrstly in ethanol and then in HEPES buﬀer (50mM
HEPES, 150mM NaCl, pH 7.4). The modiﬁed electrodes were stored in
HEPES buﬀer at 4 °C until use.
2.3.4. Sensor measurements
The modiﬁed electrodes were immersed in HEPES buﬀer and elec-
trochemically interrogated using square wave voltammetry (SWV, at a
frequency of 60 Hz and with an amplitude of 25mV and a step potential
of 5 mV) until a stable signal was obtained. After addition of the target
enzyme, the SWV signal was continuously monitored with time, with
the resulting signal decrease being expressed as the relative change in
SWV peak current with respect to the initial peak current (henceforth
shown as a negative % signal change).
2.3.5. Blood sample treatment for activated/non-activated PMNs
Freshly isolated PMNs – obtained from healthy donors following the
blood preparation protocol previously described (Avlonitis et al., 2013)
– were re-suspended at 2× 106 cells/mL in PBS containing 0.9 mM
Ca2+ and 0.5mM Mg2+. The sample was divided in two tubes, and to
one of them A23187 (a calcium ionophore, 10 µM ﬁnal concentration)
was added in order to activate the PMNs. The other one was kept non-
activated as a negative control. Both tubes were heated at 37 °C for
10min in a water bath and then centrifuged for 5min. The cell pellet
was discarded and the supernatant stored at −20 °C until use.
3. Results and discussion
The sensing platform was based on the immobilisation of a redox-
labelled peptide sequence, which contained a speciﬁc cleavage site for
the enzyme, on a gold surface as a SAM. The peptide sequence (APE-
EIMRRQ) has been reported as a highly speciﬁc HNE cleavable se-
quence in a ﬂuorescent assay for HNE detection (Avlonitis et al., 2013).
A novel peptide probe has been designed and synthesised, adding fur-
ther functionality to this previously reported sequence. In order to
generate an HNE electrochemical probe, a methylene blue redox tag
was attached to the amino-terminus of the peptide with the addition of
a 2-unit ethylene glycol moiety (PEG-2) and a cysteine at the carboxy-
terminus, which enables facile SAM immobilisation of the probe
through the formation of a S-Au bond (Fig. 1A). A probe containing the
equivalent non-cleavable D-amino acid sequence was also synthesised
as a negative control probe. The sensing mechanism relies on speciﬁc
enzyme-catalysed cleavage followed by the release of the labelled
peptide fragment from the SAM-modiﬁed gold surface into solution
(Fig. 1B). This results in a decrease of the electrochemical signal, which
is interrogated before and during enzyme exposure by square wave
voltammetry (SWV) and presented as a negative % signal change (a
decrease in the relative peak SWV current with respect to the initial
value recorded before enzyme addition). The cleavage site, im-
mediately after the methionine residue, was conﬁrmed in solution
through cleavage fragment mass analyses by MALDI-TOF MS (Fig. S1).
The sensing surfaces were generated using a previously optimised
ternary-SAM (T-SAM) conﬁguration (González-Fernández et al., 2016)
established as showing enhanced SAM biosensing, according to the
protocol detailed in Section 2.3.2. This is denoted a ternary-SAM as it is
composed of 3 diﬀerent thiols on the gold surface: the peptide-probe, a
co-adsorbed pegylated dithiol and mercaptohexanol.
3.1. Analytical performance against varying HNE concentrations
Substrate-modiﬁed gold electrodes were prepared and their per-
formance evaluated upon immersion in solutions containing varying
HNE concentrations (10–150 nM). The modiﬁed-electrodes were elec-
trochemically interrogated by SWV in real-time when exposed to dif-
ferent HNE concentrations (Fig. 2). As shown in Fig. 2A the presence of
HNE caused a decrease of the % signal, and as expected, the higher the
HNE concentration the faster the % signal change recorded, resulting
from faster proteolytic cleavage of the SAM-modiﬁed surface; where the
(negative) % signal change = (ISWV(t) - ISWV(t=0))/ ISWV(t=0)
×100, with ISWV (t=0) deﬁned as the signal recorded before the ad-
dition of the enzyme. As previously observed for other SAM systems,
the signal did not decrease by 100%, suggesting that a subset of the
immobilised peptides are not available for cleavage, which has been
previously attributed to polycrystalline gold roughness leading to site
inaccessibility (González-Fernández et al., 2018). Furthermore, addi-
tional cyclic voltammetry was performed in order to calculate the
change of surface coverage of active methylene blue-peptide upon HNE
incubation (100 nM), which showed the expected decrease, consistent
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with the SWV data (Fig. S2, Supplementary material). It is interesting
that the signal value, A, at the end of the measurements (90min); where
A is the normalised signal at time t, calculated readily from the data as
A(t) =(% signal change (t)) / (% signal change at long times (t → ∞)
and at high HNE concentration (150 nM)) varies linearly with HNE
concentration (Fig. 2B) and shows a dynamic range for sensing up to
100 nM. The limit of detection (LOD) after 90min was determined to be
4 nM, calculated as the protease concentration corresponding to the %
signal change equal to that of the blank signal ([HNE] = 0 nM) minus
3×SD, where SD is the standard deviation for the blank. Although this
is a facile single point measurement and analysis, which should be
prone to relatively large error, it is interesting that this value is lower
than previously reported values for a peptide-labelled ﬂuorescence
assay (Ferreira et al., 2017) and a peptide-based assay with quartz
crystal microbalance (QCM) detection (Stair et al., 2009), but still
higher than those reported for assays using antibodies or aptamers (Bai
et al., 2017; Dunn et al., 1985; He et al., 2010), which however, also
require several incubations and/or washing steps as opposed to the
proposed platform (see comparison in Table S1, Supplementary mate-
rial). Furthermore, the platform showed good reproducibility, with a
5% coeﬃcient of variation (n= 3) for 100 nM HNE. Interestingly, this
covers the clinically relevant range previously reported for HNE levels
in moderate and severe pneumonia, 4–10 nM, respectively (Matsuse
et al., 2007). It should be noted that for such single point measurements
the choice of time at which the measurement is taken can be selected in
order to tune the requirements of the particular sensing application. As
shown in Fig. S3, measuring at a longer time allows enhanced dis-
crimination in the lower part of the enzyme concentration range. On
the other hand, at shorter times, i.e. 8 min, a good sensing performance
in the higher part of the concentration range was observed. Examples of
the square wave voltammograms obtained for 100 nM HNE at diﬀerent
times are shown in Fig. 2C.
Fig. 1. (A) Structure of the methylene blue-tagged peptide
probe for HNE. (B) Principle of detection for the peptide-
based electrochemical biosensor. HNE catalyses the clea-
vage of the methylene blue-labelled peptide substrate re-
leasing the redox containing fragment into solution,
leading to a decrease in the electrochemical signal as
measured by SWV.
Fig. 2. Electrochemical detection of HNE. (A) % Signal
change-time course for substrate-modiﬁed electrodes im-
mersed in varying HNE concentrations (0, 10, 50, 75, 100
and 150 nM) in HEPES buﬀer. (B) Adjusted signal, A (%),
after 90min plotted against the concentration of HNE. The
straight line corresponds to the best linear ﬁt (%S =
−0.92 [HNE] (nM) + 95.92; r2 = 0.99). (C) SWV curves
registered at diﬀerent incubation times (0, 5, 10, 20, 60
and 90min) for 100 nM HNE in HEPES buﬀer. All data
points represent the average and standard deviation for
typically 3 individual sensing phases.
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3.2. Kinetic analysis of enzymatic cleavage
As an alternative to analysis of data collected at selected individual
times, which is subject to a relatively large error, the % signal decrease
registered for the varying HNE concentrations as a function of time was
measured and analysed using a Michaelis-Menten kinetic model pre-
viously established for an equivalent sensing platform for the protease
trypsin (González-Fernández et al., 2016). The fraction of cleavable
peptide cleaved at time t (θ(t) =1 – A(t)) was plotted as a function of
time (t) and ﬁtted to the previously reported model through the equa-
tion:
= =
− −θ A1–e , or e ,kt kt (1)
where k is the eﬀective cleavage rate constant. As shown in Fig. S4,
good ﬁts were obtained for HNE concentrations up to 75 nM, whereas
poorer ﬁts were obtained for higher concentrations (100 and 150 nM)
using this model. It can be seen that the origin of this deviation from the
proposed model is the fast signal change recorded at higher con-
centrations of HNE; after enzyme addition, there is an initial rapid drop
on the registered electrochemical signal, which is followed by a slower
decrease. The second slower step is attributed to the following enzyme
cleavage step. In order to prove this hypothesis, longer time data from
Fig. 2A, were ﬁtted to the above model, which allows choice of the
initial time, t0, and value of A, A0, such that,
= − −A A k t texp ( ( )).0 0 (2)
As shown in Fig. 3A, ﬁtting these data from Fig. 2A starting at t0
=8min to Eq. (2) generated good ﬁts across the entire enzyme con-
centration range tested. The ﬁt allowed extraction of a k value for each
of the HNE concentrations. We speculate that this initial signal drop,
which is increasingly apparent at enzyme concentrations above
100 nM, originates from an initial adsorption of a near monolayer of the
enzyme onto the sensor surface through enzyme-substrate binding at
these relatively large peptide-substrate surface concentrations, which
inhibits peptide ﬂexibility and hinders the approach of the redox tag to
the electrode surface, thereby decreasing the peak current without re-
sulting in cleavage. It is interesting that the dependence of k on the HNE
concentration did not follow the previously observed hyperbolic per-
formance for an analogue sensing platform for trypsin. We speculate
that this kinetic behaviour could arise from the formation of a near
monolayer of protease that slowly cleaves the surface-immobilised la-
belled-peptide at a constant rate. In the low protease concentration
range, an increase on the amount of enzyme leads to a higher amount of
protease bound to the substrate-modiﬁed surface, as determined by the
aﬃnity constant. The observed increase in the cleavage rate is then due
to the increase in surface bound HNE, each of which progressively
cleaves surface peptide at a constant rate. An increase on the cleavage
rate is then registered until a closely packed bound protease surface
layer is formed, which occurs at a relatively low point on the binding
curve (low number of surface peptides bound) due to the massive dif-
ference between the size of HNE and surface-bound probe. At this point
(HNE concentrations greater than 100 nM) the surface is saturated with
a monolayer of HNE, leading to a constant cleavage rate. This is similar
to, and consistent with, previously reported data on a surface-based
enzymatic ampliﬁcation processes for enhanced sensing which em-
ployed streptavidin-biotin binding of the large protein and subsequent
insoluble product deposition (Kaatz et al., 2012).
3.3. Selectivity study
The sensing platform was assessed in terms of selectivity towards
HNE in comparison with potential interferences from real samples (i.e.
from other components of the sample). Both substrate and control-
modiﬁed surfaces were exposed to diﬀerent solutions containing ca-
thepsin G (100 nM), a serine protease also present in PMNs; BSA
(100 nM) and casein (100 nM) as means of evaluating non-speciﬁc in-
teractions; and ions such as calcium (1mM). The electrochemical SWV
signal was monitored for 90min and the ﬁnal value plotted as % signal
change. As shown in Fig. 4A, the sensing platform exhibited low cross-
reactivity against non-speciﬁc proteins (BSA and casein), which is
consistent with the ability of such T-SAMs to enhance anti-fouling
properties (Campuzano et al., 2011; González-Fernández et al., 2016).
It is worth noting that cross-reactivity against cathepsin G was ob-
served, with the substrate-modiﬁed surface showing a 27% signal
change in presence of 100 nM cathepsin G, constituting about half of
the signal registered for the same concentration of HNE. The control-
modiﬁed surface showed no cleavage with either HNE or cathepsin G.
An equivalent output was obtained when assessing the HNE/cathepsin
G selectivity in terms of peptide cleavage rate from the electrode sur-
face (Fig. S5), Fitting to Eq. (2) allowed extraction of a k of
0.032 ± 0.003min−1, which is half of the value obtained for the same
concentration of HNE, 0.064 ± 0.003min−1. These results contrast
with the high selectivity shown in an analogous ﬂuorescent system
based on the same peptide sequence, and conﬁrmed in solution for the
substrate probe used in this study (Fig. S1, Supplementary material),
which can perhaps be attributed to the likelihood that the im-
mobilisation of the probe as an oriented, densely packed layer on a solid
support can also modify the peptide's binding and recognition proper-
ties. Indeed, the presence of arginine residues in the peptide sequence
could be the source of such cross-reactivity, as cathepsin G has been
described to cleave after positively-charged residues (Korkmaz et al.,
2011). We speculate that, the orientation of the immobilised peptide on
the electrode surface could enhance the importance of these arginine
residues on the recognition event with cathepsin G. It should be noted
that this cross-reactivity does not impede the application of the pro-
posed sensing platform to detecting PMN activity in blood samples, as
cathepsin G is also simultaneously released from activated PMNs.
The presence of calcium ions (1mM) was seen to produce a small
Fig. 3. (A) Fractional cleavage vs time plot for
substrate-modiﬁed electrode cleavage from
Fig. 2A upon immersion in diﬀerent HNE
concentrations, being t0 =8min. Solid lines
represent the best non-linear ﬁt according to
Eq. (2). (B) Variation of the eﬀective constant
rate, k, obtained from ﬁtting the data as a
function of the HNE concentration. Each of the
points represent k values obtained from ﬁttings
to Eq. (2) shown in Fig. 3A.
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increase in the SWV signal, perhaps arising from complexation of the
PEG-based spacer and/or the glutamic acid residues with the Ca2+ ions,
which could bring the redox tag closer to the electrode surface and thus,
enhance the probability of electron transfer.
3.4. Sensing HNE in real samples from human blood
HNE (and cathepsin G) is secreted by PMNs, the most abundant
blood leukocytes (Di Carlo et al., 2001). The sensing platform was
therefore challenged with activated PMNs from human blood as a
means of interrogating its ability to work in a clinically relevant setting.
Non-activated PMNs were used as a negative control. Blood samples
from 3 diﬀerent healthy donors were processed following the protocol
detailed in Section 2.3.4 in order to activate (+) /non-activate (-)
PMNs, which leads to the release/non-release of HNE. Both substrate-
and control-modiﬁed electrodes were immersed in each sample and the
SWV registered in real-time. Plotting the % signal change after 90min
for both surfaces enabled a clear discrimination between the activated
((+)–HNE) and non-activated ((-)–HNE) samples for all 3 donors
(Fig. 4B). Indeed, for each tested donor the % signal change registered
for both substrate and control surfaces was signiﬁcantly diﬀerent for
the (+)–HNE samples, in contrast to the non-signiﬁcant diﬀerence
found for (-)–HNE ones. There was a slight diﬀerence in performance
for the 3 samples tested, attributable to natural donor-to-donor varia-
bility and the presence of endogenous HNE (e.g. donors with low level
infection) or to slight variability of blood preparation causing activation
of the PMNs. Additionally, the performance of the sensing platform for
both substrate and control-modiﬁed surfaces in real samples was sub-
jected to kinetic analysis, ﬁtting the registered signal to Eq. (2). Fig. S6
shows the ﬁttings for the 3 samples tested, and the extracted k values
are summarised in Table 1. From these data we concluded that kinetic
analysis also allows discrimination between the activated and the non-
activated samples, as extracted k values for the substrate- and control-
modiﬁed surfaces corresponding to the activated samples diﬀer by an
order of magnitude in all cases, meaning that the HNE cleavage leads a
signiﬁcant and measurable signal. On the other hand, for non-activated
samples, registered k values for substrate and control-modiﬁed surfaces
were of the same order of magnitude, indicating that the eﬀect of the
small signal decrease registered (probably due to non-speciﬁc adsorp-
tion of species from these complex samples onto the modiﬁed surface) is
not signiﬁcant.
4. Conclusions
We report a peptide-based electrochemical biosensor for the speciﬁc
detection of the serine protease HNE. The platform was based on the
immobilisation, via a SAM, of a methylene blue-labelled peptide se-
quence, that acts as substrate for the enzyme. Enzymatic cleavage leads
to release of the redox reporter and a decrease of the electrochemical
signal, as measured by SWV. The proposed system enabled clinically
relevant HNE detection between 10 and 150 nM through analysing the
signal change as a function of time following a Michaelis-Menten based
kinetic model. High selectivity towards the target enzyme was achieved
when compared to non-speciﬁc proteins although, a degree of cross-
reactivity was observed for a related serine protease, cathepsin G, at-
tributed to diﬀerences in the oriented surface-bound target probe,
perhaps originating from the arginine residues within the target probe
sequence. A D-amino acid peptide analogue was used as negative
control for all measurements and showed no activation. Finally, the
sensing platform was successfully applied for sensing HNE and cathe-
psin G activity from PMNs isolated from human blood, enabling dis-
crimination between activated and un-activated polymorphonuclear
neutrophils in clinically relevant samples.
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Fig. 4. % Signal change registered for both substrate- (grey columns) and
control-modiﬁed (patterned columns) electrodes after 90min incubation with
(A) HNE (100 nM), BSA (100 nM), casein (100 nM), Ca2+ (1mM) and cathepsin
G (100 nM) in 50mM HEPES buﬀer; (B) (+) activated/(-) non-activated PMNs
from pre-treated blood samples from 3 diﬀerent healthy donors (D1–3).
*** P < 0.01; * P < 0.1; ns= non-signiﬁcant by one-way ANOVA with Tukey
post-test. All values correspond to average and standard deviation of typically 3
individual modiﬁed-electrodes.
Table 1
Values of k (min−1) obtained from ﬁtting Eq. (2) to the data registered for
substrate- and control-modiﬁed surfaces upon immersion in activated/non-ac-
tivated real samples for 3 donors.
Donor No. (Activated/non-
activated)
k (min−1) for
substrate
k (min−1) for control
Donor-1 (Activated) 0.076 ± 0.003 − 0.0047 ± 0.0005
Donor-1 (Non-activated) 0.014 ± 0.002 0.004 ± 0.002
Donor-2 (Activated) 0.051 ± 0.002 0.004 ± 0.002
Donor-2 (Non-activated) 0.0029 ± 0.0004 0.0023 ± 0.0004
Donor-3 (Activated) 0.026 ± 0.003 0.0010 ± 0.0004
Donor-3 (Non-activated) 0.016 ± 0.004 0.0058 ± 0.0009
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